The efficacy and safety of pravastatin in patients aged 60 to 85 years with lew-density lipoprotein cholesterol > 160 mg/dl
- 1 January 1996
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Cardiology
- Vol. 77 (1), 83-85
- https://doi.org/10.1016/s0002-9149(97)89140-0
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Reduction in coronary events during treatment with pravastatinThe American Journal of Cardiology, 1995
- 802-6 The Cost-Effectiveness of Pravastatin in Secondary Prevention of Coronary Heart DiseaseJournal of the American College of Cardiology, 1995
- Efficacy and safety of pravastatin in the long-term treatment of elderly patients with hypercholesterolemiaAmerican Journal Of Medicine, 1994
- Cholesterol Lowering in the ElderlyArchives of Internal Medicine, 1994
- Pravastatin experience in elderly and non-elderly patientsAtherosclerosis, 1993
- Estimation of the Concentration of Low-Density Lipoprotein Cholesterol in Plasma, Without Use of the Preparative UltracentrifugeClinical Chemistry, 1972